The Boeing Company
The Boeing Company (BA.SW) Financial Performance & Income Statement Overview
Analyze The Boeing Company (BA.SW) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
The Boeing Company (BA.SW) Income Statement & Financial Overview
Review The Boeing Company BA.SW income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $15.24B | $17.84B | $16.87B | $16.57B |
| Cost of Revenue | $16.83B | $21.35B | $15.64B | $14.69B |
| Gross Profit | -$1.59B | -$3.51B | $1.23B | $1.88B |
| Gross Profit Ratio | -$0.10 | -$0.20 | $0.07 | $0.11 |
| R&D Expenses | $836.00M | $1.15B | $954.00M | $868.00M |
| SG&A Expenses | $1.40B | $1.08B | $1.38B | $1.16B |
| Operating Expenses | $2.18B | $2.25B | $2.33B | $2.03B |
| Total Costs & Expenses | $19.01B | $23.60B | $17.97B | $16.72B |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $755.00M | $728.00M | $673.00M | $569.00M |
| Depreciation & Amortization | $509.00M | $444.00M | $441.00M | $442.00M |
| EBITDA | -$2.83B | -$5.05B | -$401.00M | $510.00M |
| EBITDA Ratio | -$0.19 | -$0.28 | -$0.02 | $0.03 |
| Operating Income | -$3.77B | -$5.76B | -$1.09B | -$86.00M |
| Operating Income Ratio | -$0.25 | -$0.32 | -$0.06 | -$0.005 |
| Other Income/Expenses (Net) | -$323.00M | -$463.00M | -$425.00M | -$292.00M |
| Income Before Tax | -$4.09B | -$6.22B | -$1.51B | -$378.00M |
| Income Before Tax Ratio | -$0.27 | -$0.35 | -$0.09 | -$0.02 |
| Income Tax Expense | -$232.00M | -$50.00M | -$76.00M | -$23.00M |
| Net Income | -$3.87B | -$6.17B | -$1.44B | -$343.00M |
| Net Income Ratio | -$0.25 | -$0.35 | -$0.09 | -$0.02 |
| EPS | -$5.30 | -$9.97 | -$2.33 | -$0.56 |
| Diluted EPS | -$5.30 | -$9.97 | -$2.33 | -$0.56 |
| Weighted Avg Shares Outstanding | $718.10M | $618.86M | $616.30M | $612.90M |
| Weighted Avg Shares Outstanding (Diluted) | $718.10M | $618.86M | $616.30M | $612.90M |
The company's financials show resilient growth, with revenue advancing from $16.57B in Q1 2024 to $15.24B in Q4 2024. Gross profit remained healthy with margins at -10% in Q4 2024 compared to 11% in Q1 2024. Operating income hit -$3.77B last quarter, sustaining a consistent -25% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at -$2.83B. Net income rose to -$3.87B, while earnings per share reached -$5.30. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan